Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis

BACKGROUND: Diabetic macular edema (DME) is an important cause of vision loss and despite the anatomical and functional improvement achieved with treatment, there are reports of persistent DME regardless of continuous anti-VEGF therapy. The purpose of this study is to examine the effect of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Babiuch, Amy S., Conti, Thais F., Conti, Felipe F., Silva, Fabiana Q., Rachitskaya, Aleksandra, Yuan, Alex, Singh, Rishi P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647124/
https://www.ncbi.nlm.nih.gov/pubmed/31367468
http://dx.doi.org/10.1186/s40942-019-0167-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647124/
https://www.ncbi.nlm.nih.gov/pubmed/31367468
http://dx.doi.org/10.1186/s40942-019-0167-x

Ejemplares similares